OBJECTIVE: The COVID-19 Emergency Department (COVED) Quality Improvement Project aims to provide regular and real-time clinical information to ED clinicians caring for patients with suspected and confirmed COVID-19. The present study summarises data from the first 2 weeks of the study. METHODS: COVED is an ongoing prospective cohort study that commenced on 1 April 2020. It includes all adult patients presenting to a participating ED who undergo testing for SARS-CoV-2. Data are collected prospectively and entered into a bespoke registry. Outcomes include a positive SARS-CoV-2 polymerase chain reaction test result and requirement for intensive respiratory support. RESULTS: In the period 1-14 April 2020, 240 (16%) of 1508 patients presenting to The Alfred Emergency and Trauma Centre met inclusion criteria. Of these, 11 (5%) tested positive for SARS-CoV-2. The mean age of patients was 60 years and the commonest symptoms were acute shortness of breath (n = 122 [67%]), cough (n = 108 [56%]) or fever (n = 98 [51%]). Overseas travel or known contact with a confirmed case was reported by 24 (14%) and 16 (10%) patients, respectively. Fever or hypoxia was recorded in 23 (10%) and 11 (5%) patients, respectively. Eleven (5%) patients received mechanical ventilation in the ED, of whom none tested positive for SARS-CoV-2. CONCLUSIONS: Among patients presenting to a tertiary ED with suspected COVID-19, only a small proportion tested positive for SARS-CoV-2. Although the low incidence of positive cases currently precludes the development of predictive tools, the COVED Project demonstrates that the rapid establishment of an agile clinical registry for emergency care is feasible.
OBJECTIVE: The COVID-19 Emergency Department (COVED) Quality Improvement Project aims to provide regular and real-time clinical information to ED clinicians caring for patients with suspected and confirmed COVID-19. The present study summarises data from the first 2 weeks of the study. METHODS: COVED is an ongoing prospective cohort study that commenced on 1 April 2020. It includes all adult patients presenting to a participating ED who undergo testing for SARS-CoV-2. Data are collected prospectively and entered into a bespoke registry. Outcomes include a positive SARS-CoV-2 polymerase chain reaction test result and requirement for intensive respiratory support. RESULTS: In the period 1-14 April 2020, 240 (16%) of 1508 patients presenting to The Alfred Emergency and Trauma Centre met inclusion criteria. Of these, 11 (5%) tested positive for SARS-CoV-2. The mean age of patients was 60 years and the commonest symptoms were acute shortness of breath (n = 122 [67%]), cough (n = 108 [56%]) or fever (n = 98 [51%]). Overseas travel or known contact with a confirmed case was reported by 24 (14%) and 16 (10%) patients, respectively. Fever or hypoxia was recorded in 23 (10%) and 11 (5%) patients, respectively. Eleven (5%) patients received mechanical ventilation in the ED, of whom none tested positive for SARS-CoV-2. CONCLUSIONS: Among patients presenting to a tertiary ED with suspected COVID-19, only a small proportion tested positive for SARS-CoV-2. Although the low incidence of positive cases currently precludes the development of predictive tools, the COVED Project demonstrates that the rapid establishment of an agile clinical registry for emergency care is feasible.
Authors: Thomas Struyf; Jonathan J Deeks; Jacqueline Dinnes; Yemisi Takwoingi; Clare Davenport; Mariska Mg Leeflang; René Spijker; Lotty Hooft; Devy Emperador; Julie Domen; Sebastiaan R A Horn; Ann Van den Bruel Journal: Cochrane Database Syst Rev Date: 2021-02-23
Authors: Javier Trigo; David García-Azorín; Álvaro Planchuelo-Gómez; Enrique Martínez-Pías; Blanca Talavera; Isabel Hernández-Pérez; Gonzalo Valle-Peñacoba; Paula Simón-Campo; Mercedes de Lera; Alba Chavarría-Miranda; Cristina López-Sanz; María Gutiérrez-Sánchez; Elena Martínez-Velasco; María Pedraza; Álvaro Sierra; Beatriz Gómez-Vicente; Juan Francisco Arenillas; Ángel L Guerrero Journal: J Headache Pain Date: 2020-07-29 Impact factor: 7.277
Authors: Nicola Fink; Johannes Rueckel; Sophia Kaestle; Vincent Schwarze; Eva Gresser; Boj Hoppe; Jan Rudolph; Sophia Goller; Wolfgang G Kunz; Jens Ricke; Bastian O Sabel Journal: BMC Infect Dis Date: 2021-02-10 Impact factor: 3.090
Authors: Gerard M O'Reilly; Rob D Mitchell; Biswadev Mitra; Michael P Noonan; Ryan Hiller; Lisa Brichko; Carl Luckhoff; Andrew Paton; De Villiers Smit; Peter A Cameron Journal: Emerg Med Australas Date: 2020-06-27 Impact factor: 2.279
Authors: Biswadev Mitra; Carl Luckhoff; Rob D Mitchell; Gerard M O'Reilly; De Villiers Smit; Peter A Cameron Journal: Emerg Med Australas Date: 2020-08-17 Impact factor: 2.279
Authors: Gerard M O'Reilly; Rob D Mitchell; Biswadev Mitra; Hamed Akhlaghi; Viet Tran; Jeremy S Furyk; Paul Buntine; Holly Bannon-Murphy; Timothy Amos; Maushmi Udaya Kumar; Emma Perkins; Alexandra Prentice; Olivia Szwarcberg; Ashley Loughman; Nicole Lowry; Steven Colwell; Michael P Noonan; Ryan Hiller; Andrew Paton; De Villiers Smit; Peter A Cameron Journal: Emerg Med Australas Date: 2020-10-19 Impact factor: 2.279
Authors: Gerard M O'Reilly; Rob D Mitchell; Jamin Wu; Prithi Rajiv; Holly Bannon-Murphy; Timothy Amos; Lisa Brichko; Helen Brennecke; Michael P Noonan; Biswadev Mitra; Andrew Paton; Ryan Hiller; De Villiers Smit; Carl Luckhoff; Mark J Santamaria; Peter A Cameron Journal: Emerg Med Australas Date: 2020-07-16 Impact factor: 2.279
Authors: Rob D Mitchell; Gerard M O'Reilly; Biswadev Mitra; De Villiers Smit; Jean-Philippe Miller; Peter A Cameron Journal: Emerg Med Australas Date: 2020-08-29 Impact factor: 2.279